Literature DB >> 2459054

Preparation of both DNA and RNA for hybridization analysis from limiting quantities of lymphoid cells.

M J Pearse1, L Wu.   

Abstract

This report describes a method for preparing both DNA and RNA simultaneously from as few as 5 X 10(5) lymphoid cells. The method is suitable for cultured cells or any tissue from which a cell suspension can be prepared and for the small samples of purified cells obtained by fluorescence activated cell sorting. Cells are lysed with Nonidet P-40 and the nuclear and cytoplasmic fractions separated by centrifugation. Nuclei are embedded in low-gelling-temperature agarose and the proteinase K and restriction enzyme digestions performed whilst the DNA is immobilized in this form. Total RNA is prepared from the cytoplasmic fraction. This method is simple but reliable and is therefore particularly useful for preparing and analyzing the DNA and RNA from multiple samples when material is limited.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459054     DOI: 10.1016/0165-2478(88)90022-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells.

Authors:  D Vremec; M Zorbas; R Scollay; D J Saunders; C F Ardavin; L Wu; K Shortman
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

2.  A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor.

Authors:  M Pearse; L Wu; M Egerton; A Wilson; K Shortman; R Scollay
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

3.  Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung.

Authors:  C Saltini; M Kirby; B C Trapnell; N Tamura; R G Crystal
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.